Together, these findings suggest that the activation of PPARγ may represent a novel therapeutic strategy for IBD and that this approach may have therapeutic effects by restoring the balance of macrophage polarization and reducing excessive inflammation in the intestinal mucosa. This evidence concerns the gene PPARG and inflammatory bowel disease.